287 related articles for article (PubMed ID: 28856406)
21. Differential antagonism by naloxone benzoylhydrazone of the activation of inward rectifying K+ channels by nociceptin and a mu-opioid in rat periaqueductal grey slices.
Chiou LC
Naunyn Schmiedebergs Arch Pharmacol; 2001 Jun; 363(6):583-9. PubMed ID: 11414652
[TBL] [Abstract][Full Text] [Related]
22. Roles of nociceptin/orphanin FQ and nociceptin/orphanin FQ peptide receptor in respiratory rhythm generation in the medulla oblongata: an in vitro study.
Takita K; Morimoto Y; Kemmotsu O
Br J Anaesth; 2003 Sep; 91(3):385-9. PubMed ID: 12925479
[TBL] [Abstract][Full Text] [Related]
23. Neuroanatomical and neuropharmacological study of opioid pathways in the mesencephalic tectum: effect of mu(1)- and kappa-opioid receptor blockade on escape behavior induced by electrical stimulation of the inferior colliculus.
Osaki MY; Castellan-Baldan L; Calvo F; Carvalho AD; Felippotti TT; de Oliveira R; Ubiali WA; Paschoalin-Maurin T; Elias-Filho DH; Motta V; da Silva LA; Coimbra NC
Brain Res; 2003 Dec; 992(2):179-92. PubMed ID: 14625057
[TBL] [Abstract][Full Text] [Related]
24. Endocannabinoid neuromodulation in the neostriatum decreases the GABAergic striato-nigral disinhibitory function and increases the nigro-collicular inhibitory pathway activity.
da Silva JA; Almada RC; de Paiva YB; Coimbra NC
J Neural Transm (Vienna); 2020 Aug; 127(8):1199-1208. PubMed ID: 32533255
[TBL] [Abstract][Full Text] [Related]
25. Activation of nociceptin/orphanin FQ receptors inhibits contextual fear memory reconsolidation.
Rekik K; Faria Da Silva R; Colom M; Pacifico S; Zaveri NT; Calo' G; Rampon C; Frances B; Mouledous L
Neuropharmacology; 2017 Oct; 125():39-49. PubMed ID: 28705439
[TBL] [Abstract][Full Text] [Related]
26. Dopamine-nociceptin/orphanin FQ interactions in the substantia nigra reticulata of hemiparkinsonian rats: involvement of D2/D3 receptors and impact on nigro-thalamic neurons and motor activity.
Volta M; Viaro R; Trapella C; Marti M; Morari M
Exp Neurol; 2011 Mar; 228(1):126-37. PubMed ID: 21215744
[TBL] [Abstract][Full Text] [Related]
27. Defense reaction mediated by NMDA mechanisms in the inferior colliculus is modulated by GABAergic nigro-collicular pathways.
Nobre MJ; Lopes MG; Brandão ML
Brain Res; 2004 Feb; 999(1):124-31. PubMed ID: 14746929
[TBL] [Abstract][Full Text] [Related]
28. Topographic and functional neuroanatomical study of GABAergic disinhibitory striatum-nigral inputs and inhibitory nigrocollicular pathways: neural hodology recruiting the substantia nigra, pars reticulata, for the modulation of the neural activity in the inferior colliculus involved with panic-like emotions.
Castellan-Baldan L; da Costa Kawasaki M; Ribeiro SJ; Calvo F; Corrêa VM; Coimbra NC
J Chem Neuroanat; 2006 Aug; 32(1):1-27. PubMed ID: 16820278
[TBL] [Abstract][Full Text] [Related]
29. Chemical neuroanatomical and psychopharmacological evidence that κ receptor-mediated endogenous opioid peptide neurotransmission in the dorsal and ventral mesencephalon modulates panic-like behaviour.
da Silva JA; de Freitas RL; Eichenberger GC; Padovan CM; Coimbra NC
Eur J Pharmacol; 2013 Jan; 698(1-3):235-45. PubMed ID: 23397604
[TBL] [Abstract][Full Text] [Related]
30. Mu-opioid peptide (MOP) and nociceptin/orphanin FQ peptide (NOP) receptor activation both contribute to the discriminative stimulus properties of cebranopadol in the rat.
Tzschentke TM; Rutten K
Neuropharmacology; 2018 Feb; 129():100-108. PubMed ID: 29155273
[TBL] [Abstract][Full Text] [Related]
31. µ- and κ-Opioid receptor activation in the dorsal periaqueductal grey matter differentially modulates panic-like behaviours induced by electrical and chemical stimulation of the inferior colliculus.
Twardowschy A; Coimbra NC
Brain Res; 2015 Feb; 1597():168-79. PubMed ID: 25485771
[TBL] [Abstract][Full Text] [Related]
32. Interactions between opioid-peptides-containing pathways and GABA(A)-receptors-mediated systems modulate panic-like-induced behaviors elicited by electric and chemical stimulation of the inferior colliculus.
Calvo F; Coimbra NC
Brain Res; 2006 Aug; 1104(1):92-102. PubMed ID: 16797498
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological characterization of nociceptin/orphanin FQ receptors, a novel opioid receptor family, in the midbrain periaqueductal gray.
Chiou LC; Fan SH; Chuang KC; Liao YY; Lee SZ
Ann N Y Acad Sci; 2004 Oct; 1025():398-403. PubMed ID: 15542742
[TBL] [Abstract][Full Text] [Related]
34. NOP receptors in the prelimbic cortex have an inhibitory influence on cardiovascular responses induced by restraint stress.
Fassini A; Scopinho AA; Resstel LB; Corrêa FM
Neuropeptides; 2016 Jun; 57():35-44. PubMed ID: 26935148
[TBL] [Abstract][Full Text] [Related]
35. Nociceptin/orphanin FQ receptor antagonists as innovative antidepressant drugs.
Gavioli EC; Calo' G
Pharmacol Ther; 2013 Oct; 140(1):10-25. PubMed ID: 23711793
[TBL] [Abstract][Full Text] [Related]
36. Role of nociceptin/orphanin FQ and NOP receptors in the response to acute and repeated restraint stress in rats.
Delaney G; Dawe KL; Hogan R; Hunjan T; Roper J; Hazell G; Lolait SJ; Fulford AJ
J Neuroendocrinol; 2012 Dec; 24(12):1527-41. PubMed ID: 22835008
[TBL] [Abstract][Full Text] [Related]
37. Nociceptin/orphanin FQ peptide receptors: pharmacology and clinical implications.
Chiou LC; Liao YY; Fan PC; Kuo PH; Wang CH; Riemer C; Prinssen EP
Curr Drug Targets; 2007 Jan; 8(1):117-35. PubMed ID: 17266536
[TBL] [Abstract][Full Text] [Related]
38. Characterization of nociceptin/orphanin FQ-induced pain responses by the novel receptor antagonist N-(4-amino-2-methylquinolin-6-yl)-2-(4-ethylphenoxymethyl) benzamide monohydrochloride.
Muratani T; Minami T; Enomoto U; Sakai M; Okuda-Ashitaka E; Kiyokane K; Mori H; Ito S
J Pharmacol Exp Ther; 2002 Oct; 303(1):424-30. PubMed ID: 12235279
[TBL] [Abstract][Full Text] [Related]
39. Pharmacological blockage of NOP receptors decreases ventral tegmental area dopamine neuronal activity through GABA
Petrella M; Borruto AM; Curti L; Domi A; Domi E; Xu L; Barbier E; Ilari A; Heilig M; Weiss F; Mannaioni G; Masi A; Ciccocioppo R
Neuropharmacology; 2024 May; 248():109866. PubMed ID: 38364970
[TBL] [Abstract][Full Text] [Related]
40. Nociceptin/orphanin FQ receptor activation attenuates antinociception induced by mixed nociceptin/orphanin FQ/mu-opioid receptor agonists.
Khroyan TV; Polgar WE; Jiang F; Zaveri NT; Toll L
J Pharmacol Exp Ther; 2009 Dec; 331(3):946-53. PubMed ID: 19713488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
